MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14.12.2021
voting rights
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
23.12.2021
voting rights
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
31.01.2022
voting rights
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
02.02.2022
voting rights
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
03.02.2022
voting rights
21
Apr
2022
16
Feb
2022
SVB Leerink 11th Annual Global Healthcare Conference
Jean-Paul Kress, M.D. (CEO, MorphoSys) presents the Company on 2.16.22 at 8:00AM – 8:30AM ET / 2:00pm – 2:30pm CET.
16
Nov
2022
03
Aug
2022